Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.

Biotechnology

Acticor Biotech

Gilles Avenard

Bérengère Hennebelle

Jessica Jami

Munoz Alain

Antoine Lebel

Sandra Lourenço-Lopes

Alexandra Brochand

Véronia Safwat

Sophie Binay

Marion Galaup

Elie Toledano

Yannick Plétan

Clinical Operations Team

Medical Team

Regulatory and Quality Team

Scientific & Pharmaceutical Development

Leadership Team

Teams at Acticor Biotech

Clinical Operations Team

Medical Team

Regulatory and Quality Team

Scientific & Pharmaceutical Development

Leadership Team